OPKO Health Inc (NASDAQ:OPK) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products. OPKO Health Inc has a market cap of $1.69 billion; its shares were traded at around $2.74 with and P/S ratio of 1.61.
For the last quarter OPKO Health Inc reported a revenue of $249.8 million, compared with the revenue of $263.5 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $990.3 million, a decrease of 7.2% from the previous year. For the last five years OPKO Health Inc had an average revenue growth rate of 76.7% a year.
The reported loss per diluted share was 27 cents for the year, compared with the loss per share of $0.41 in the previous year. The OPKO Health Inc had an operating margin of -16.78%, compared with the operating margin of -26.56% a year before. The 10-year historical median operating margin of OPKO Health Inc is -76.43%. The profitability rank of the company is 4 (out of 10).
At the current stock price of $2.74, OPKO Health Inc is traded at 94.4% discount to its historical median P/S valuation band of $48.85. The P/S ratio of the stock is 1.61, while the historical median P/S ratio is 28.42. The stock lost 13.84% during the past 12 months.
CEO Recent Trades:
CEO & Chairman, 10% Owner Phillip Frost bought 200,000 shares of OPK stock on 02/28/2019 at the average price of $2.48. The price of the stock has increased by 10.48% since.For the complete 20-year historical financial data of OPK, click here.
No comments:
Post a Comment